Women with PMOS should have yearly NHS checks, says health watchdog
The draft guidance says 4 million women with irregular periods should be assessed for PMOS and offered annual reviews to improve diagnosis and care.
- The National Institute for Health and Care Excellence issued new draft guidelines recommending annual health reviews for women with polyendocrine metabolic ovarian syndrome to improve consistency of care and long-term health management.
- Health officials recently renamed the condition from polycystic ovarian syndrome to PMOS after global experts highlighted that many women face diagnosis delays due to misunderstanding about cysts and ovarian focus.
- Nice noted the condition affects between three and four million women in the UK but remains 'frequently underdiagnosed and inconsistently managed,' underscoring the need for structured oversight.
- Regarding treatment, Nice advised against laser or light therapies for hirsutism, citing a 'lack of clinical evidence and uncertainty about cost-effectiveness,' as these could cost the NHS up to £100 million yearly.
- Fresh guidance mandates investigating all women with irregular menstrual cycles for PMOS, yet the primary challenge remains ensuring NHS services possess resources for consistent implementation across the UK.
9 Articles
9 Articles
Irregular period? New NHS guidelines recommend testing for PMOS – a hormone disorder affecting millions of women.
Millions of women with irregular periods to be offered checks under new NHS guidance
Draft NHS guidance published by the National Institute for Health and Care Excellence calls for millions of women experiencing irregular menstrual cycles to undergo screening for a chronic hormonal disorder.The recommendations target those with absent or disrupted periods who also display indicators of elevated male hormones, urging investigation for polyendocrine metabolic ovarian syndrome (PMOS).Approximately one in eight women across Britain …
The Independent
The Independent (US)The ‘common but overlooked’ condition that millions of women will now be reviewed for
Women with polyendocrine metabolic ovarian syndrome (PMOS) should be seen yearly by health officials to monitor symptoms and treatment, Nice said
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
